RDY

Dr Reddy's Laboratories Limited
D

RDY

13.940
USD
-0.28
(-1.97%)
مغلق
حجم التداول
0
الربح لكل سهم
77
العائد الربحي
0.66
P/E
18
حجم السوق
11,603,249,649
التوصيات
Moustafa El khaldy
Moustafa El khaldy
منذ سنة
sell
RDY
RDY @76.07
2024-07-05 05:47
RDY@76.07 Chart
الربح
9,319.50
81.67%
المزيد
أصول ذات صلة
AZN
AZN
0.880
(1.20%)
73.960 USD
GSK
GSK
0.402
(1.08%)
37.557 USD
LLY
LLY
22.87
(3.09%)
762.54 USD
MRK
MRK
1.157
(1.48%)
79.300 USD
NVS
NVS
1.540
(1.35%)
115.280 USD
PFE
PFE
0.185
(0.79%)
23.470 USD
SNY
SNY
1.115
(2.44%)
46.765 USD
TEVA
TEVA
-0.060
(-0.39%)
15.395 USD
المزيد
الأخبار المقالات

العنوان: Dr. Reddy's Laboratories Ltd

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.